Showing results (61-70 of 265) with videos related to

Sort By:
Pageof 27
Climacteric : the Journal of the International Menopause Society|March 20, 2025
The impact of ovarian aging on muscle strength and life quality in various reproductive aging stagesAiyue Luo, Hongyu Li, Xing Lv, et al.
Cell Reports|October 24, 2023
A circRNA therapy based on Rnf103 to inhibit Vibrio anguillarum infectionWeiwei Zheng, Xing Lv, Yaqi Tao, et al.
Cell Death & Disease|August 31, 2023
CircMIB2 therapy can effectively treat pathogenic infection by encoding a novel proteinWeiwei Zheng, Linchao Wang, Shang Geng, et al.
Investigational New Drugs|January 12, 2022
IMB5036, a novel pyridazinone compound, inhibits hepatocellular carcinoma growth and metastasisXing Lv, Qi Zhao, Yanqun Dong, et al.
Chinese Journal of Natural Medicines|December 5, 2016
Food-advanced glycation end products aggravate the diabetic vascular complications via modulating the AGEs/RAGE pathwayXing Lv, Gao-Hong Lv, Guo-Ying Dai, et al.
Current Pharmaceutical Design|April 7, 2021
ADAMTS9-AS2: A Functional Long Non-coding RNA in TumorigenesisWen Xu, Bei Wang, Yuxuan Cai, et al.
Fish & Shellfish Immunology|October 7, 2023
Identification and functional regulation of three alternative splicing isoforms of the fthl27 gene in miiuy croaker, Miichthys miiuyQiang Luo, Xuefeng Zhou, Xing Lv, et al.
World Neurosurgery|August 2, 2025
Treatment of Pyogenic Ventriculitis with Retroauricular External Ventricular DrainageXi Liu, Fan Zhang, Xing Lv, et al.
Frontiers in Public Health|April 29, 2026
Drug resistance characteristics and risk factors in patients with retreated pulmonary tuberculosis: a 5-year retrospective study in Suzhou, ChinaQinhao Zhou, Yanyang Zhou, Xing Lv, et al.
Oncotargets and Therapy|July 6, 2022
Response of Scalp and Skull Metastasis to Anti-PD-1 Antibody Combined with Regorafenib Treatment in a Sorafenib-Resistant Hepatocellular Carcinoma Patient and a Literature ReviewXin Long, Lei Zhang, Wen-Qiang Wang, et al.
Pageof 27